Trial to Evaluate the Efficacy and Safety of IVIEW-1201 in Acute Bacterial Conjunctivitis

NCT05816070 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

129

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Bacterial Conjunctivitis

Interventions

DRUG: IVIEW-1201
DRUG: Ofloxacin Eye Drops

Sponsor

IVIEW Therapeutics Inc.